HK1255584A1 - 使用阿坎酸及d-環絲胺酸的聯合療法 - Google Patents
使用阿坎酸及d-環絲胺酸的聯合療法Info
- Publication number
- HK1255584A1 HK1255584A1 HK18114711.9A HK18114711A HK1255584A1 HK 1255584 A1 HK1255584 A1 HK 1255584A1 HK 18114711 A HK18114711 A HK 18114711A HK 1255584 A1 HK1255584 A1 HK 1255584A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- acamprosate
- cycloserine
- combination therapy
- therapy
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562200864P | 2015-08-04 | 2015-08-04 | |
| PCT/US2016/045547 WO2017024129A1 (en) | 2015-08-04 | 2016-08-04 | Combination therapy using acamprosate and d-cycloserine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1255584A1 true HK1255584A1 (zh) | 2019-08-23 |
Family
ID=57944041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18114711.9A HK1255584A1 (zh) | 2015-08-04 | 2018-11-16 | 使用阿坎酸及d-環絲胺酸的聯合療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20180221315A1 (zh) |
| EP (1) | EP3331518A4 (zh) |
| JP (2) | JP2018526345A (zh) |
| KR (1) | KR20180034442A (zh) |
| AU (2) | AU2016303610A1 (zh) |
| CA (1) | CA2993614A1 (zh) |
| HK (1) | HK1255584A1 (zh) |
| IL (1) | IL257035A (zh) |
| SG (1) | SG10201914045QA (zh) |
| WO (1) | WO2017024129A1 (zh) |
| ZA (1) | ZA201800558B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018526345A (ja) * | 2015-08-04 | 2018-09-13 | コンフルーエンス ファーマシューティカルズ，エルエルシー | アカンプロセートおよびｄ−サイクロセリンを使用する組み合わせ療法 |
| KR102608479B1 (ko) | 2017-05-25 | 2023-12-01 | 글리테크 엘엘씨. | Nmdar 길항제-반응성 신경정신 질환을 위한 병용 요법 |
| US11291654B2 (en) | 2018-09-13 | 2022-04-05 | Syneurx International (Taiwan) Corp. | Formulations of cycloserine compounds and applications thereof |
| WO2023171106A1 (ja) * | 2022-03-08 | 2023-09-14 | ソシウム株式会社 | Ｔｄｐ－４３の凝集の抑制剤、ｔｄｐ－４３が過剰発現している細胞の細胞死の抑制剤、及びｔｄｐ－４３の凝集を伴う疾患の治療又は予防剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2219924C2 (ru) * | 1998-04-14 | 2003-12-27 | Дзе Дженерал Хоспитал Корпорейшн | Способ лечения нейропсихиатрических расстройств |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP2167068A2 (en) * | 2007-07-05 | 2010-03-31 | Inserm-Institut National De La Sante Et De La Recherche Medicale | Anticonvulsive pharmaceutical compositions |
| CA2781830C (en) * | 2009-02-12 | 2018-03-27 | Indiana University Research & Technology Corporation | Materials and methods for treating developmental disorders including comorbid and idiopathic autism |
| US20100216805A1 (en) * | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| EP2727473A4 (en) * | 2011-06-28 | 2015-05-06 | Vivozon Inc | COMBINATION OF EFFICIENT SUBSTANCES WITH SYNERGISTIC EFFECTS OF MULTIPLE TARGETING AND USE THEREOF |
| EP3291800A4 (en) * | 2015-05-04 | 2018-09-26 | Confluence Pharmaceuticals, LLC | Sprinkle formulations of acamprosate |
| JP2018526345A (ja) * | 2015-08-04 | 2018-09-13 | コンフルーエンス ファーマシューティカルズ，エルエルシー | アカンプロセートおよびｄ−サイクロセリンを使用する組み合わせ療法 |
-
2016
- 2016-08-04 JP JP2018504281A patent/JP2018526345A/ja active Pending
- 2016-08-04 SG SG10201914045QA patent/SG10201914045QA/en unknown
- 2016-08-04 WO PCT/US2016/045547 patent/WO2017024129A1/en active Application Filing
- 2016-08-04 CA CA2993614A patent/CA2993614A1/en not_active Abandoned
- 2016-08-04 US US15/749,705 patent/US20180221315A1/en not_active Abandoned
- 2016-08-04 EP EP16833870.5A patent/EP3331518A4/en not_active Withdrawn
- 2016-08-04 KR KR1020187002542A patent/KR20180034442A/ko not_active Application Discontinuation
- 2016-08-04 AU AU2016303610A patent/AU2016303610A1/en not_active Abandoned
-
2018
- 2018-01-21 IL IL257035A patent/IL257035A/en unknown
- 2018-01-26 ZA ZA201800558A patent/ZA201800558B/en unknown
- 2018-11-16 HK HK18114711.9A patent/HK1255584A1/zh unknown
-
2020
- 2020-06-02 US US16/890,533 patent/US20200360316A1/en not_active Abandoned
-
2021
- 2021-06-22 JP JP2021103459A patent/JP2021152060A/ja active Pending
-
2022
- 2022-04-01 AU AU2022202218A patent/AU2022202218A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017024129A1 (en) | 2017-02-09 |
| AU2016303610A1 (en) | 2018-02-01 |
| JP2018526345A (ja) | 2018-09-13 |
| US20180221315A1 (en) | 2018-08-09 |
| IL257035A (en) | 2018-03-29 |
| CA2993614A1 (en) | 2017-02-09 |
| JP2021152060A (ja) | 2021-09-30 |
| EP3331518A1 (en) | 2018-06-13 |
| KR20180034442A (ko) | 2018-04-04 |
| EP3331518A4 (en) | 2019-04-03 |
| AU2022202218A1 (en) | 2022-04-21 |
| ZA201800558B (en) | 2019-10-30 |
| US20200360316A1 (en) | 2020-11-19 |
| SG10201914045QA (en) | 2020-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263521A (en) | Combination therapy | |
| IL258931A (en) | Medicinal compounds and methods | |
| IL257976A (en) | Combined treatment | |
| GB201516442D0 (en) | Combination therapy | |
| IL265406B (en) | combined treatment | |
| HK1255110A1 (zh) | 組合療法 | |
| GB201609597D0 (en) | Therapy | |
| HK1255584A1 (zh) | 使用阿坎酸及d-環絲胺酸的聯合療法 | |
| GB201604318D0 (en) | Combination therapy | |
| GB201604316D0 (en) | Combination therapy | |
| IL265340A (en) | Combination therapy | |
| GB201617470D0 (en) | Novel therapy | |
| GB201609735D0 (en) | Combination therapy | |
| GB201603653D0 (en) | Combination Therapy | |
| GB201618477D0 (en) | Therapy | |
| GB201615923D0 (en) | Macrophage-based therapy | |
| GB201703070D0 (en) | Therapy | |
| GB201609721D0 (en) | Cobination therapy | |
| GB201609312D0 (en) | Therapy | |
| GB201609322D0 (en) | Therapy | |
| GB201613179D0 (en) | Combination therapy | |
| GB201609770D0 (en) | Combination therapy | |
| GB201609766D0 (en) | Combination therapy | |
| GB201609722D0 (en) | Combination therapy | |
| GB201609719D0 (en) | Combination therapy |